(Q53314344)

13 May 2018

title

The vitamin D system: a crosstalk between the heart and kidney. (English)

1 reference

13 May 2018

0 references

1

1 reference

13 May 2018

author name string

Markus Ketteler

series ordinal

2

1 reference

13 May 2018

Daniel Zehnder

series ordinal

3

1 reference

13 May 2018

publication date

6 July 2010

1 reference

13 May 2018

European Journal of Heart Failure

published in

1 reference

13 May 2018

volume

12

1 reference

13 May 2018

issue

10

1 reference

13 May 2018

page(s)

1031-1041

1 reference

13 May 2018

Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Metabolism and Mechanism of Action of Vitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Putting cardiovascular disease and vitamin D insufficiency into perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Impact of kidney bone disease and its management on survival of patients on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Impact of activated vitamin D and race on survival among hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Association of oral calcitriol with improved survival in nondialyzed CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Association of activated vitamin D treatment and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Vitamin D and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Vitamin D receptor activators can protect against vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

A bimodal association of vitamin D levels and vascular disease in children on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Expression of the vitamin d receptor is increased in the hypertrophic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Serum 25-hydroxyvitamin D, Ethnicity, and Blood Pressure in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

Vitamin D levels and patient outcome in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ112

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ112

1 reference

13 May 2018

PubMed ID

20605845

1 reference

13 May 2018